Hey guys
So PXS has some big phase 2 trial results in July - does anyone have any knowledge that reduces the pass/ fail risk of this company when the results come out?
Specifically, are there reasons that put the success of PXS's clinical trials beyond a flip of a coin?
regards
bruutz82